Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 623

1.

Simple non-mydriatic retinal photography is feasible and demonstrates retinal microvascular dilation in Chronic Obstructive Pulmonary Disease (COPD).

McKay GJ, McCarter RV, Hogg RE, Higbee DH, Bajaj MK, Burrage DR, Ruickbie S, Baker EH, Jones PW, Dodd JW.

PLoS One. 2020 Jan 10;15(1):e0227175. doi: 10.1371/journal.pone.0227175. eCollection 2020.

2.

Heart rate score predicts mortality independent of shocks in ICD and CRT-D patients.

Olshansky B, Richards M, Sharma AD, Jones PW, Wold N, Perschbacher D, Wilkoff BL.

J Interv Card Electrophysiol. 2019 Dec 24. doi: 10.1007/s10840-019-00688-8. [Epub ahead of print]

PMID:
31875270
3.

Clinical Development and Research Applications of the COPD Assessment Test (CAT).

Müllerová H, Dransfield MT, Thomashow B, Jones PW, Rennard S, Karlsson N, Fageras M, Metzdorf N, Petruzzelli S, Rommes J, Sciurba FC, Tabberer M, Merrill D, Tal-Singer R; COPD Biomarker Qualification Consortium and the CAT Governance Board.

Am J Respir Crit Care Med. 2019 Dec 9. doi: 10.1164/rccm.201907-1369PP. [Epub ahead of print]

PMID:
31815521
4.

CAT score single item analysis in patients with COPD: Results from COSYCONET.

Marietta von Siemens S, Alter P, Lutter JI, Kauczor HU, Jobst B, Bals R, Trudzinski FC, Söhler S, Behr J, Watz H, Waschki B, Bewig B, Jones PW, Welte T, Vogelmeier CF, Jörres RA, Kahnert K; COSYCONET study group; Names of participating study nurses.

Respir Med. 2019 Nov;159:105810. doi: 10.1016/j.rmed.2019.105810. Epub 2019 Nov 7.

PMID:
31739262
5.

Contributions of cardiovascular risk and smoking to chronic obstructive pulmonary disease (COPD)-related changes in brain structure and function.

Spilling CA, Bajaj MK, Burrage DR, Ruickbie S, Thai NJ, Baker EH, Jones PW, Barrick TR, Dodd JW.

Int J Chron Obstruct Pulmon Dis. 2019 Aug 21;14:1855-1866. doi: 10.2147/COPD.S213607. eCollection 2019.

6.

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial.

Maltais F, Bjermer L, Kerwin EM, Jones PW, Watkins ML, Tombs L, Naya IP, Boucot IH, Lipson DA, Compton C, Vahdati-Bolouri M, Vogelmeier CF.

Respir Res. 2019 Oct 30;20(1):238. doi: 10.1186/s12931-019-1193-9.

7.

Disruption of white matter connectivity in chronic obstructive pulmonary disease.

Spilling CA, Jones PW, Dodd JW, Barrick TR.

PLoS One. 2019 Oct 3;14(10):e0223297. doi: 10.1371/journal.pone.0223297. eCollection 2019.

8.

Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting.

Whittaker HR, Müllerova H, Jarvis D, Barnes NC, Jones PW, Compton CH, Kiddle SJ, Quint JK.

Int J Chron Obstruct Pulmon Dis. 2019 May 23;14:1063-1073. doi: 10.2147/COPD.S200919. eCollection 2019.

9.

A synthesis of ecosystem management strategies for forests in the face of chronic nitrogen deposition.

Clark CM, Richkus J, Jones PW, Phelan J, Burns DA, de Vries W, Du E, Fenn ME, Jones L, Watmough SA.

Environ Pollut. 2019 May;248:1046-1058. doi: 10.1016/j.envpol.2019.02.006. Epub 2019 Feb 8. Review.

PMID:
31091637
10.

The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition.

Kim V, Zhao H, Regan E, Han MK, Make BJ, Crapo JD, Jones PW, Curtis JL, Silverman EK, Criner GJ; COPDGene Investigators.

Chest. 2019 Oct;156(4):685-695. doi: 10.1016/j.chest.2019.03.041. Epub 2019 May 15.

PMID:
31047955
11.

Development and first validation of a patient-reported experience measure in chronic obstructive pulmonary disease (PREM-C9).

Hodson M, Roberts CM, Andrew S, Graham L, Jones PW, Yorke J.

Thorax. 2019 Jun;74(6):600-603. doi: 10.1136/thoraxjnl-2018-211732. Epub 2019 Apr 26.

PMID:
31028236
12.

Outcomes and costs of remote patient monitoring among patients with implanted cardiac defibrillators: An economic model based on the PREDICT RM database.

Hummel JP, Leipold RJ, Amorosi SL, Bao H, Deger KA, Jones PW, Kansal AR, Ott LS, Stern S, Stein K, Curtis JP, Akar JG.

J Cardiovasc Electrophysiol. 2019 Jul;30(7):1066-1077. doi: 10.1111/jce.13934. Epub 2019 Apr 29.

13.

A pilot study to test the feasibility of histological characterisation of asthma-COPD overlap.

Papakonstantinou E, Savic S, Siebeneichler A, Strobel W, Jones PW, Tamm M, Stolz D.

Eur Respir J. 2019 Jun 5;53(6). pii: 1801941. doi: 10.1183/13993003.01941-2018. Print 2019 Jun. No abstract available.

PMID:
30880282
14.

Association of Medication Intensity and Stages of Airflow Limitation With the Risk of Hospitalization or Death in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.

Lawson CA, Mamas MA, Jones PW, Teece L, McCann G, Khunti K, Kadam UT.

JAMA Netw Open. 2018 Dec 7;1(8):e185489. doi: 10.1001/jamanetworkopen.2018.5489.

15.

COPD patients hospitalized with exacerbations have greater cognitive impairment than patients hospitalized with decompensated heart failure.

Bajaj MK, Burrage DR, Tappouni A, Dodd JW, Jones PW, Baker EH.

Clin Interv Aging. 2018 Dec 18;14:1-8. doi: 10.2147/CIA.S185981. eCollection 2019.

16.

Long-term outcomes following first short-term clinically important deterioration in COPD.

Naya IP, Tombs L, Muellerova H, Compton C, Jones PW.

Respir Res. 2018 Nov 20;19(1):222. doi: 10.1186/s12931-018-0928-3.

17.

A randomized trial of symptom-based management in Japanese patients with COPD.

Betsuyaku T, Kato M, Fujimoto K, Kobayashi A, Hayamizu T, Hitosugi H, Hagan G, James MH, Jones PW.

Int J Chron Obstruct Pulmon Dis. 2018 Aug 13;13:2409-2423. doi: 10.2147/COPD.S152723. eCollection 2018.

18.

Chronic kidney disease, worsening renal function and outcomes in a heart failure community setting: A UK national study.

Lawson CA, Testani JM, Mamas M, Damman K, Jones PW, Teece L, Kadam UT.

Int J Cardiol. 2018 Sep 15;267:120-127. doi: 10.1016/j.ijcard.2018.04.090.

19.

Subthalamic Nucleus Neurons Differentially Encode Early and Late Aspects of Speech Production.

Lipski WJ, Alhourani A, Pirnia T, Jones PW, Dastolfo-Hromack C, Helou LB, Crammond DJ, Shaiman S, Dickey MW, Holt LL, Turner RS, Fiez JA, Richardson RM.

J Neurosci. 2018 Jun 13;38(24):5620-5631. doi: 10.1523/JNEUROSCI.3480-17.2018. Epub 2018 May 22.

20.

Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.

Brouwer TF, Knops RE, Kutyifa V, Barr C, Mondésert B, Boersma LVA, Lambiase PD, Wold N, Jones PW, Healey JS.

Europace. 2018 Sep 1;20(FI2):f240-f248. doi: 10.1093/europace/euy083.

PMID:
29771327
21.

Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator.

Theuns DAMJ, Brouwer TF, Jones PW, Allavatam V, Donnelley S, Auricchio A, Knops RE, Burke MC.

Heart Rhythm. 2018 Oct;15(10):1515-1522. doi: 10.1016/j.hrthm.2018.05.011. Epub 2018 Jun 8.

22.

Risk Factors and Temporal Trends of Complications Associated With Transvenous Implantable Cardiac Defibrillator Leads.

Koneru JN, Jones PW, Hammill EF, Wold N, Ellenbogen KA.

J Am Heart Assoc. 2018 May 10;7(10). pii: e007691. doi: 10.1161/JAHA.117.007691.

23.

The distribution of blood eosinophil levels in a Japanese COPD clinical trial database and in the rest of the world.

Barnes N, Ishii T, Hizawa N, Midwinter D, James M, Hilton E, Jones PW.

Int J Chron Obstruct Pulmon Dis. 2018 Feb 2;13:433-440. doi: 10.2147/COPD.S144108. eCollection 2018.

24.

Genetic mapping of quantitative trait loci for tuber-cadmium and zinc concentration in potato reveals associations with maturity and both overlapping and independent components of genetic control.

Mengist MF, Alves S, Griffin D, Creedon J, McLaughlin MJ, Jones PW, Milbourne D.

Theor Appl Genet. 2018 Apr;131(4):929-945. doi: 10.1007/s00122-017-3048-4. Epub 2018 Jan 6.

PMID:
29307117
25.

Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease.

Donohue JF, Jones PW, Bartels C, Marvel J, D'Andrea P, Banerji D, Morris DG, Patalano F, Fogel R.

Pulm Pharmacol Ther. 2018 Apr;49:11-19. doi: 10.1016/j.pupt.2017.12.005. Epub 2017 Dec 19. Review.

PMID:
29277690
26.

Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification.

Lawson CA, Jones PW, Teece L, Dunbar SB, Seferovic PM, Khunti K, Mamas M, Kadam UT.

JACC Heart Fail. 2018 Jan;6(1):18-26. doi: 10.1016/j.jchf.2017.08.020. Epub 2017 Oct 11.

27.

Cadmium uptake and partitioning in potato (Solanum tuberosum L.) cultivars with different tuber-Cd concentration.

Mengist MF, Milbourne D, Griffin D, McLaughlin MJ, Creedon J, Jones PW, Alves S.

Environ Sci Pollut Res Int. 2017 Dec;24(35):27384-27391. doi: 10.1007/s11356-017-0325-3. Epub 2017 Oct 3.

PMID:
28975479
28.

Socioeconomic Status as a Determinant of Health Status Treatment Response in COPD Trials.

Jones PW, Gelhorn H, Wilson H, Benson VS, Karlsson N, Menjoge S, Müllerova H, Rennard SI, Tal-Singer R, Merrill D, Tabberer M.

Chronic Obstr Pulm Dis. 2017 Apr 1;4(2):150-158. doi: 10.15326/jcopdf.4.2.2017.0132.

29.

St George's Respiratory Questionnaire Score Predicts Outcomes in Patients with COPD: Analysis of Individual Patient Data in the COPD Biomarkers Qualification Consortium Database.

Müllerova H, Gelhorn H, Wilson H, Benson VS, Karlsson N, Menjoge S, Rennard SI, Tabberer M, Tal-Singer R, Merrill D, Jones PW.

Chronic Obstr Pulm Dis. 2017 Mar 28;4(2):141-149. doi: 10.15326/jcopdf.4.2.2017.0131.

30.

Baseline Severity as Predictor of Change in St George's Respiratory Questionnaire Scores in Trials of Long-acting Bronchodilators with COPD Patients.

Jones PW, Gelhorn H, Karlsson N, Menjoge S, Müllerova H, Rennard SI, Tal-Singer R, Wilson H, Merrill D, Tabberer M.

Chronic Obstr Pulm Dis. 2017 Mar 21;4(2):132-140. doi: 10.15326/jcopdf.4.2.2017.0129.

31.

Responder Analyses for Treatment Effects in COPD Using the St George's Respiratory Questionnaire.

Jones PW, Gelhorn H, Wilson H, Karlsson N, Menjoge S, Müllerova H, Rennard SI, Tal-Singer R, Merrill D, Tabberer M.

Chronic Obstr Pulm Dis. 2017 Mar 2;4(2):124-131. doi: 10.15326/jcopdf.4.2.2017.0130.

32.

The COPD Biomarkers Qualification Consortium Database: Baseline Characteristics of the St George's Respiratory Questionnaire Dataset.

Tabberer M, Benson VS, Gelhorn H, Wilson H, Karlsson N, Müllerova H, Menjoge S, Rennard SI, Tal-Singer R, Merrill D, Jones PW.

Chronic Obstr Pulm Dis. 2017 Mar 13;4(2):112-123. doi: 10.15326/jcopdf.4.2.2017.0128.

33.

The COPD Biomarkers Qualification Consortium St George's Respiratory Questionnaire Manuscripts: Output of a Consortium to Advance Drug Development.

Tabberer M, Jones PW.

Chronic Obstr Pulm Dis. 2017 Feb 28;4(2):109-111. doi: 10.15326/jcopdf.4.2.2017.0127. No abstract available.

34.

A preliminary study to estimate contact rates between free-roaming domestic dogs using novel miniature cameras.

Bombara CB, Dürr S, Machovsky-Capuska GE, Jones PW, Ward MP.

PLoS One. 2017 Jul 27;12(7):e0181859. doi: 10.1371/journal.pone.0181859. eCollection 2017.

35.

Cardiovascular Disease Does Not Predict Exacerbation Rate or Mortality in Chronic Obstructive Pulmonary Disease.

Jones PW, Mullerova H, Agusti A, Decramer M, Adamek L, Raillard A, Zhu CQ, Wedzicha JA.

Am J Respir Crit Care Med. 2018 Feb 1;197(3):400-403. doi: 10.1164/rccm.201706-1066LE. No abstract available.

36.

White matter lesions characterise brain involvement in moderate to severe chronic obstructive pulmonary disease, but cerebral atrophy does not.

Spilling CA, Jones PW, Dodd JW, Barrick TR.

BMC Pulm Med. 2017 Jun 19;17(1):92. doi: 10.1186/s12890-017-0435-1.

37.

Evaluation of the psychometric properties of the St George's Respiratory Questionnaire in patients with severe asthma.

Nelsen LM, Vernon M, Ortega H, Cockle SM, Yancey SW, Brusselle G, Albers FC, Jones PW.

Respir Med. 2017 Jul;128:42-49. doi: 10.1016/j.rmed.2017.04.015. Epub 2017 Apr 30.

38.

Addition of Blood Pressure and Weight Transmissions to Standard Remote Monitoring of Implantable Defibrillators and its Association with Mortality and Rehospitalization.

Al-Chekakie MO, Bao H, Jones PW, Stein KM, Marzec L, Varosy PD, Masoudi FA, Curtis JP, Akar JG.

Circ Cardiovasc Qual Outcomes. 2017 May;10(5). pii: e003087. doi: 10.1161/CIRCOUTCOMES.116.003087.

PMID:
28506978
39.

Rescue medication use as a patient-reported outcome in COPD: a systematic review and regression analysis.

Punekar YS, Sharma S, Pahwa A, Takyar J, Naya I, Jones PW.

Respir Res. 2017 May 8;18(1):86. doi: 10.1186/s12931-017-0566-1. Review.

40.

Qualitative evaluation of the St George's Respiratory Questionnaire in patients with severe asthma.

Nelsen LM, Kimel M, Murray LT, Ortega H, Cockle SM, Yancey SW, Brusselle G, Albers FC, Jones PW.

Respir Med. 2017 May;126:32-38. doi: 10.1016/j.rmed.2017.02.021. Epub 2017 Feb 28.

41.

Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes.

Hackett G, Jones PW, Strange RC, Ramachandran S.

World J Diabetes. 2017 Mar 15;8(3):104-111. doi: 10.4239/wjd.v8.i3.104.

42.

Consumer segmentation and time interval between types of hospital admission: a clinical linkage database study.

Kadam UT, Lawson CA, Moody DK, Teece L, Uttley J, Harvey J, Iqbal Z, Jones PW.

J Public Health (Oxf). 2018 Mar 1;40(1):154-162. doi: 10.1093/pubmed/fdx028.

PMID:
28334927
43.

Near infrared spectroscopy for body fat sensing in neonates: quantitative analysis by GAMOS simulations.

Mustafa FH, Jones PW, McEwan AL.

Biomed Eng Online. 2017 Jan 11;16(1):14. doi: 10.1186/s12938-016-0310-y.

44.

Echocardiographic abnormalities and their impact on health status in patients with COPD referred for pulmonary rehabilitation.

Houben-Wilke S, Spruit MA, Uszko-Lencer NHMK, Otkinska G, Vanfleteren LEGW, Jones PW, Wouters EFM, Franssen FME.

Respirology. 2017 Jul;22(5):928-934. doi: 10.1111/resp.12968. Epub 2016 Dec 21.

PMID:
28001000
45.

Interpreting patient-reported outcomes from clinical trials in COPD: a discussion.

Jones PW, Rennard S, Tabberer M, Riley JH, Vahdati-Bolouri M, Barnes NC.

Int J Chron Obstruct Pulmon Dis. 2016 Dec 7;11:3069-3078. eCollection 2016. Review.

46.

Vitamin D deficiency: What does it mean for chronic obstructive pulmonary disease (COPD)? a compherensive review for pulmonologists.

Kokturk N, Baha A, Oh YM, Young Ju J, Jones PW.

Clin Respir J. 2018 Feb;12(2):382-397. doi: 10.1111/crj.12588. Epub 2017 Jan 5. Review.

PMID:
27925404
47.

Length-free near infrared measurement of newborn malnutrition.

Mustafa FH, Bek EJ, Huvanandana J, Jones PW, Carberry AE, Jeffery HE, Jin CT, McEwan AL.

Sci Rep. 2016 Nov 8;6:36052. doi: 10.1038/srep36052.

48.

Improvements in Lung Diffusion Capacity following Pulmonary Rehabilitation in COPD with and without Ventilation Inhomogeneity.

Santus P, Radovanovic D, Balzano G, Pecchiari M, Raccanelli R, Sarno N, Di Marco F, Jones PW, Carone M.

Respiration. 2016;92(5):295-307. Epub 2016 Sep 7.

49.

Patterns of physical activity and survival following cardiac resynchronization therapy implantation: the ALTITUDE activity study.

Kramer DB, Jones PW, Rogers T, Mitchell SL, Reynolds MR.

Europace. 2017 Nov 1;19(11):1841-1847. doi: 10.1093/europace/euw267.

50.

A Scoring Application for the St. George's Respiratory Questionnaire.

Gelpi M, Argentiero J, Jones PW, Ronit A.

Chest. 2016 Sep;150(3):747-8. doi: 10.1016/j.chest.2016.05.029. No abstract available.

PMID:
27613980

Supplemental Content

Loading ...
Support Center